前往化源商城

入驻化源商城

品牌现货直购

131262-82-3

131262-82-3结构式

常用中文名：Butanoic acid,1,1',1''-[(2R,3R,4R,5S)-1-butyl-2-[(1-oxobutoxy)methyl]-3,4,5-piperidinetriyl]ester
常用英文名：Butanoic acid,1,1',1''-[(2R,3R,4R,5S)-1-butyl-2-[(1-oxobutoxy)methyl]-3,4,5-piperidinetriyl]ester
CAS号：131262-82-3
分子式：C₂₆H₄₅NO₈
分子量：499.63700
发布时间：2016-12-28 09:54:48
更新时间：2024-04-03 09:57:55

化源商城直购

英文名	[(2R,3R,4R,5S)-3,4,5-tri(butanoyloxy)-1-butylpiperidin-2-yl]methyl butanoate
英文别名	Perbutylated-N-butyl-1-deoxynojiromycin N-Butyl DNJ Prodrug Glycovir DRG-0193 Butanoic acid,1-butyl-2-((1-oxobutoxy)methyl)-3,4,5-piperidinetriyl ester,(2R-(2alpha,3beta,4alpha,5beta))

密度	1.09g/cm3
沸点	524ºC at 760mmHg
分子式	C₂₆H₄₅NO₈
分子量	499.63700
闪点	270.7ºC
精确质量	499.31500
PSA	108.44000
LogP	3.88760
蒸汽压	4.48E-11mmHg at 25°C
折射率	1.488

CHEMICAL IDENTIFICATION

RTECS NUMBER :: EK7713970

CHEMICAL NAME :: Butanoic acid, 1-butyl-2-((1-oxobutoxy)methyl)-3,4,5-piperidinetriyl ester, (2R-(2alpha,3beta,4alpha,5beta))-

CAS REGISTRY NUMBER :: 131262-82-3

LAST UPDATED :: 199801

DATA ITEMS CITED :: 2

MOLECULAR FORMULA :: C26-H45-N-O8

MOLECULAR WEIGHT :: 499.72

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 103 gm/kg/4W-I

TOXIC EFFECTS :: Gastrointestinal - changes in structure or function of salivary glands Gastrointestinal - changes in structure or function of endocrine pancreas Gastrointestinal - other changes

REFERENCE :: TOPADD Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978- Volume(issue)/page/year: 24,531,1996

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 218 gm/kg/26W-I

TOXIC EFFECTS :: Gastrointestinal - changes in structure or function of endocrine pancreas Gastrointestinal - other changes Endocrine - other changes

REFERENCE :: TOPADD Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978- Volume(issue)/page/year: 24,531,1996